Aurinia Pharmaceuticals
AUPH
#4681
Rank
S$2.83 B
Marketcap
S$21.27
Share price
-3.25%
Change (1 day)
35.09%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2026 (TTM): S$0.21 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are S$0.31 Billion. In 2025 the company made an earning of S$0.15 Billion, an increase over its 2024 earnings that were of S$15.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.21 B39.98%
2025 S$0.15 B864.64%
2024 S$15.69 M-116.44%
2023 -S$95.43 Million-31.8%
2022 -S$0.14 Billion-39.4%
2021 -S$0.24 Billion61.9%
2020 -S$0.15 Billion-9.73%
2019 -S$0.16 Billion92.65%
2018 -S$82.01 Million36.39%
2017 -S$60.13 Million106.29%
2016 -S$29.15 Million-15.4%
2015 -S$34.46 Million65.84%
2014 -S$20.78 Million129.82%
2013 -S$9.04 Million-26.6%
2012 -S$12.32 Million
2010 -S$6.98 Million-39.22%
2009 -S$11.48 Million-43.78%
2008 -S$20.41 Million-53.19%
2007 -S$43.6 Million42.97%
2006 -S$30.5 Million-23.03%
2005 -S$39.62 Million36.1%
2004 -S$29.12 Million172.57%
2003 -S$10.69 Million484.61%
2002 -S$1.83 Million
2000 -S$8.68 Million453.81%
1999 -S$1.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
S$6.60 B 3,041.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-S$28.27 Million-113.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-S$7.01 Million-103.34%๐Ÿ‡บ๐Ÿ‡ธ USA